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Abstract
Background: Bisbenzimides, or Hoechst 33258 (H258), and its derivative Hoechst 33342 (H342) are archetypal molecules for
designing minor groove binders, and widely used as tools for staining DNA and analyzing side population cells. They are
supravital DNA minor groove binders with AT selectivity. H342 and H258 share similar biological effects based on the
similarity of their chemical structures, but also have their unique biological effects. For example, H342, but not H258, is a
potent apoptotic inducer and both H342 and H258 can induce transgene overexpression in in vitro studies. However, the
molecular mechanisms by which Hoechst dyes induce apoptosis and enhance transgene overexpression are unclear.
Methodology/Principal Findings: To determine the molecular mechanisms underlying different biological effects between
H342 and H258, microarray technique coupled with bioinformatics analyses and multiple other techniques has been utilized
to detect differential global gene expression profiles, Hoechst dye-specific gene expression signatures, and changes in cell
morphology and levels of apoptosis-associated proteins in malignant mesothelioma cells. H342-induced apoptosis occurs in
a dose-dependent fashion and is associated with morphological changes, caspase-3 activation, cytochrome c mitochondrial
translocation, and cleavage of apoptosis-associated proteins. The antagonistic effect of H258 on H342-induced apoptosis
indicates a pharmacokinetic basis for the two dyes’ different biological effects. Differential global gene expression profiles
induced by H258 and H342 are accompanied by unique gene expression signatures determined by DNA microarray and
bioinformatics software, indicating a genetic basis for their different biological effects.
Conclusions/Significance: A unique gene expression signature associated with H342-induced apoptosis provides a new
avenue to predict and classify the therapeutic class of minor groove binders in the drug development process. Further
analysis of H258-upregulated genes of transcription regulation may identify the genes that enhance transgene
overexpression in gene therapy and promote recombinant protein products in biopharmaceutical companies.
Data Deposition: The microarray data reported in this article have been deposited in the Gene Expression Omnibus (GEO)
database, www.ncbi.nlm.nih.gov/geo (accession no.GSE28616).
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Introduction
Many research studies have aimed to target specific sequences
in DNA with the goal of designing drugs [1]. The minor groove of
DNA is becoming a site of great interest due to its high sequence
specific interactions with a large number of small molecules. DNA
minor groove binders (MBs), one of the most widely studied class
of small molecules, typically bind to AT-rich sequences of the
DNA minor groove and may be divided into two functional
classes: 1) compounds that can induce permanent DNA damage;
2) compounds that only interact physically with DNA and cause
only reversible inhibition of DNA-dependent functions [2]. The
Hoechst compounds, Hoechst 33258 (H258) [29-(4-Hydroxyphe-
nyl)-5-(4-methyl-1-piperazinyl)-2,59-bi(1H-benzimidazole)] and its
derivative Hoechst 33342 (H342) [29-(4-ethoxyphenyl)-5-(4-meth-
yl-1-piperazinyl)-2,59-bi(1H-benzimidazole)] belong to the second
functional class and are also the most studied MBs as model
compounds for biochemical and biophysical studies of drugs that
bind to the DNA minor groove. These MBs form strong reversible
complexes preferentially at the nucleotide sequences with 4–5
adjacent AT base pairs in the minor groove of double-stranded B-
DNA, where a particularly narrow groove with a floor lacking
amino groups permits an optimization of van der Waals’ contacts
and hydrogen bonding [3], [4]. As a consequence of this DNA
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interference because they share a common sequence preference
for DNA binding. Previous studies demonstrate that Hoechst dyes
interfere with multiple DNA processing proteins such as
topoisomerase I [5], [6] and II [7], DNA helicase [8], TATA
box binding protein [9], [10], E2F1 [11], and replication protein A
[12]. In fact, most proteins which bind sequence specifically to AT
rich DNA regions have extensive contacts within the minor
groove, and it is likely that inhibition of the binding of these factors
to DNA by MBs is mediated by direct steric interference [13]. In
addition, DNA sequence-specific binding MBs may be associated
with a unique gene expression pattern or drug-specific gene
expression signature since MBs only interact with minor groove
regions in disassembled chromatin where transcription and/or
replication are ongoing. Therefore, it is imperative to determine
the Hoechst dye-specific gene expression signature to uncover
potential biomarkers and Hoechst-specific signal transduction
pathways for cancer therapy.
Extensive studies show that Hoechst dyes have anti-cancer
activities like other MBs [2], [14]. Initial studies show that H258
possesses activity against L1210 murine leukemia [15] and several
promising experiments in solid tumors have led to the use of this
compound in phase I clinical trials in human [15]. However, a
subsequent phase II trial against pancreatic carcinoma shows little
response [16]. Further data demonstrate that H342, but not H258,
is a potent apoptotic inducer of different types of cancers [17].
Even so, H342 and H258 share some similar biological effects due
to their similar thermodynamic properties. For example, H342
and H258 poison topoisomerase I [5], [18], inhibit other DNA
processing proteins in in vitro studies [9], and affect the cell cycle
[19], [20]. Both dyes are found to be free radical scavengers and
protect DNA against radiation-induced damage [21]. However,
both dyes significantly enhance UV- and radio-induced cytotox-
icity as sensitizers in human tumor cell lines [22], [23].
Intriguingly, both H258 and H342 can enhance transgene
overexpression in in vitro studies [24], [25].
In addition to their similarities, both Hoechst dyes have
uniquely different biological effects in the cell as well. H342 is
several orders of magnitude more cytotoxic than H258. Large
numbers of protein-DNA cross-links and DNA strand breaks can
be detected in H342-, but not, H258-treated cells [5], [26], [27].
Early studies revealed that H342 causes rapid cell death once
sufficient dye enters the nucleus of a cell [27]. But, our later studies
show that the key difference of intracellular effects between the two
dyes is that H342, but not H258, is a potent apoptotic inducer in
different types of cancer cell lines [17] and species [28]. However,
the molecular mechanisms by which different Hoechst dyes have
diverse intracellular effects are still unclear. In chemical structure,
H342 has a 4-ethyoxy substitution on the phenyl ring that its
parent compound H258 does not, thus enhancing its membrane
permeability. This minute modification in the chemical structure
causes H342 pharmacodynamics to differ from that of H258.
Thus, H258 and H342 are not only archetypal compounds for
designing new MBs and studying the interaction of MBs with
DNA, but also contrasting compounds for identifying the
mechanisms by studying the difference of biological effects induced
by the two Hoechst dyes.
The purpose of the present study is to determine the molecular
mechanisms underlying different biological effects between H342
and H258. Our results show differential global gene expression
profiles with individually unique gene expression signatures
induced by H258 and H342. One application of these gene
expression signatures is that they can be used to predict the
effectiveness of new MBs derived from Hoechst dyes. In addition,
genes consisting of the H342-specific gene expression signature
may be invaluable targets for targeted cancer therapy. Further-
more, genes up-regulated by H258 may be utilized in transgene
overexpression in gene therapy and could promote recombinant
protein products in biopharmaceutical companies. Therefore, the
present study has highlighted the new insights into molecular and
pharmacokinetic mechanisms that cause diverse biological effects
of Hoechst 33342 and Hoechst 33258, which can aid in the
discovery of more advanced and efficient cancer treatments.
Results
Hoechst 33342 is a potent apoptosis inducer of human
mesothelioma cell lines
To test whether or not H342 may trigger cell death in
malignant pleural mesothelioma (MPM) cells, seven MPM cell
lines have been employed in this study. Cell viability results
indicate that H342 significantly induces cell death in all seven
mesothelioma cell lines in dose-dependent manners by MTT (3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
(Figure 1A). To determine the nature of this death in
mesothelioma cells induced by H342, we have used fluorescent
staining assay, Western blot, and caspase-3 activity assay to test
cell morphological changes, caspase-3 activity, and expression of
apoptosis-associated proteins during the cell death of H2373
mesothelioma cells treated by H342 for different times. The cells
shrink, become circular, and lose contact with neighboring cells as
nuclear condensation occurs, forming half-moon shapes typical of
apoptosis in a time-dependent fashion during 36 mM H342
treatment (Figure 2). The apoptotic nature of this death has been
further confirmed by measurement of caspase activation, translo-
cation of cytochrome c, and levels of apoptosis-associated proteins
in H2373 cells treated for different intervals with 36 mM H342.
Consistent with caspase 3 activation (Figure 1B), cytochrome c is
translocated from the mitochondria to the cytosol in the response
to H342 treatment (Figure 1C). Figure 1D shows that degradation
of PARP, inhibition of apoptosis protein 1 (c-IAP1), c-IAP2, and
survivin is associated with a decrease in pro-caspase 3 levels in
H342-treated H2373 cells.
Antagonistic effect of Hoechst 33258 on Hoechst 33342-
induced apoptosis
To determine the pharmacokinetic relationship between H342
and H258, we postulate that H342 and H258 share the same
transport system due to their similarities in chemical structure. To
test this hypothesis, we examined the effects of incremental doses
of H258 and H342, alone or in combination, on the cell viability
of H2373 mesothelioma cells by MTT assay. Consistent with
previous results, both MTT and cell morphological results show
that H258 fails to induce cell death after 6 hour and 24 hour
treatment at different concentrations when compared to H342-
treated and H258-pre-treated groups (Figure 3 and 4A). In
contrast, cell viability, as determined by MTT assay, reveals that
H258 decreases H342-induced apoptosis by 33% to 57% in a
dose-dependent manner (Figure 4A). Morphological data indicate
combined treatment of H342 and H258 delays cell morphological
changes at least for two hours when compared to H342 treatment
alone or H258-pretreated group, suggesting H258 effectively
delays the entry of H342 into cells (Figure 3). To further analyze
drug antagonism between the two Hoechst dyes, a dose response
curve is generated for Hoechst dyes in H2373 mesothelioma cells
using Calcusyn software (Figure 4B). Consistent with MTT data,
the combination treatment causes a significant decrease in H342-
induced apoptosis when compared to that achieved in response to
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to each treatment is utilized to perform antagonistic analysis with
Calcusyn. The CI (combination indices) as formulated by the
software, revealed values of more than 1.0, indicating an
antagonistic interaction between H258 and H342 when they are
combined (Table 1). This analysis further confirms the drug
antagonism between the two Hoechst dyes.
Differential global gene expression profiles induced by
Hoechst dyes
Since the thermodynamic features of DNA binding of H342
and H258 are similar, the pharmacokinetic differences in the entry
of H342 and H258 into cells seem to be the initial cause of the
different biological effects of Hoechst dyes [29]. Since AT rich
sequences of DNA are primary binding sites of Hoechst dyes, we
postulate that the different biological effects of Hoechst dyes
eventually stem from differential global gene expression profiles
defined by their unique gene expression signatures. To test the
hypothesis, we performed oligo microarray analysis of gene
expression profiles in H2373 mesothelioma cells after 3 hours of
36 mM H258 or H342 treatment. Utilizing data obtained from the
HumanHT-12 v4 expression BeadChip kit (Illumina), we
performed hierarchical clustering using the Mev version 4.5.1
software and constructed a dendrogram for Hoechst dye-treated
samples. The concordance between the results from the hierar-
chical cluster analysis and Venn diagram indicated that the global
gene expression pattern of H342 induction was different from that
of H258 induction, revealing differential gene expression profiles
of cells in response to H342 and H258 treatment (Figure 5). To
validate the results of our expression microarrays, we carried out
quantitative RT-PCR analysis of the RNAs used in the expression
microarray studies. We have analyzed a total of 4 genes: 2 genes
that are up-regulated in H342-treated H2373 mesothelioma cells
(Fos, JMJD7) and 2 genes that are down-regulated (SNIP1,
SMAD6) (Figure 6). As shown in Figure 6A and 6B, we are able to
confirm significant up- or down-regulation (P,0.05) as predicted
from the microarrays. Recent study shows that SNIP1 is an
important modulator of c-Myc activity [30] and c-Myc target
genes encode global chromatin regulators (e.g., CTCF and
hGCN5) and critical regulators of mitochondrial function such
Figure 1. Effect of H342 on cell viability, caspase 3 activity, cytochrome c translocation, and apoptosis-associated protein levels. A,
Effect of H342 on cell viability of 7 human mesothelioma cell lines. 7 mesothelioma cell lines were treated with different concentrations of H342 (0–
36 mM) for 24 hours. Cell viability was determined by MTT assay. Line chart represents the cell viability (%) with mean + SE. B, Measurement of
endogenous caspase 3 activity after 36 mM H342 for different times in H2373 cells. Line chart indicates relative fluorescence units with mean + SE. C,
Determination of cytochrome c translocation induced by 36 mM H342 for different times in H2373 cells. After treatment, the cytosolic and the
mitochondrial fractions were isolated by differential centrifugation. Levels of cytochrome c in cytosolic and the mitochondrial fractions were
determined by immunoblotting. D, Protein levels of poly (ADP-ribose) polymerase (PARP), inhibitor of apoptosis protein 1 and 2 (c-IAP1 and 2), and
caspase 3 were determined by immunoblotting after H2373 cells were treated with 36 mM H342 for different times.
doi:10.1371/journal.pone.0025822.g001
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hallmark of H342-induced apoptosis [32–34] we have further
chosen two c-Myc target genes (e.g., CTCF and TFAM) and
COX19 that are downregulated in H342-induced gene expression
profile to test the relevance of SNIP1-mediated c-Myc target genes
and COX19 [35] to chromatin structure/function and mitochon-
drial function [31]. Figure 7A and 7B show the downregulated
gene expression of CTCF, TFAM and COX19 induced by 36 mM
H342 treatment for 3 hour, indicating the potential molecular
basis of chromatin and mitochondria dysfunction in H342-treated
cells. Figure 7C is a schematic diagram of H342-induced
mitochondria dysfunction through SNIP1 and COX19. The
present study represents the first large-scale and high-quality
transcriptome analysis in Hoechst dye-induced gene expression.
Figure 2. Characterization of morphological changes of H2373 cells induced by H342. A-D, The morphology of the cells was
photographed with a microscope. E-H. Untreated and treated cells were rinsed with PBS buffer and stained with Hoechst 33342 (final concentration,
18 mM) for 10 minutes. After staining with Hoechst 33342, the morphological aspects of cell nuclei were observed with a fluorescence microscope.
doi:10.1371/journal.pone.0025822.g002
Figure 3. Effect of H258 on morphological changes induced by H342 in H2373 cells. H2373 mesothelioma cells were treated with H342 or
H258 alone, or combination of H342 + H258 for different times. Control: A (1h), B (3h) and C (6h); 36 mM H258-treated: D (1h), E (3H), F (6h); 36 mM
H342-treated: G (1h), H (3h), I (6h); 36 mM H258- and 36 mM H342-treated: J (1h), K (3h), L (6h).
doi:10.1371/journal.pone.0025822.g003
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Hoechst dyes
A gene signature consists of a list of genes whose expression is
correlated with the biological state of interest. Applying highly
stringent criteria, our global gene expression data have demon-
strated that 99 genes are upregulated and 582 genes are
downregulated after 3 hour H258 treatment, whereas 191 genes
are upregulated and 490 genes are downregulated after 3 hour
H342 treatment. To gain insight into the biological meaning of the
Hoechst dye–specific signatures, we used David Bioinformatics
Databases (http://david.abcc.ncifcrf.gov/) to examine the expres-
sion of a compendium of differential expression gene profiles
representing specific ontology terms in response to H258
treatment and H342 treatment, respectively [36]. To lend
biological relevance to these gene profile data, we have examined
the lists of up-and down-regulated genes for over-representation of
any functional classes using the DAVID Bioinformatics Database.
In H258-induced gene expression profiling, nine classes were
significantly over-represented among the upregulated genes of
H258 treatment. These genes are mainly involved in regulation of
transcription (26%), DNA binding (19%), response to organic
substances and nutrients (10%), and apoptosis (10%). Five
functional classes out of nine are associated with gene transcription
and DNA binding (34) (Figure 5). In contrast, 582 genes are
downregulated and found to be related to regulation of nuclear
components (chromosomes, microtubules, the nuclear body, etc.)
and nuclear biological processes (cell cycle, macromolecule
metabolism and assembly, etc.) (Figure 5). Thus, it is likely that
upregulation of the transcription regulation genes and downreg-
ulation of the nuclear structure and cell cycle genes are the
signature of the H258-induced gene expression profile. In H342-
induced gene expression profiling, twelve classes are significantly
over-represented among the upregulated genes. These genes are
involved in intracellular biological processes (signal, MAPK
signaling pathway, cell adhesion, etc.) and cellular components
such as the extracellular matrix part (Figure 5). These data suggest
that cells prevent H342-induced damage by enhancing intracel-
lular biological processes and reinforcing cellular components.
Among the down-regulated genes, thirteen classes are found to be
related to the regulation of nuclear metabolism, including nuclear
components and nuclear biological processes (Figure 5). In
contrast to the H258-downregulated gene expression profile,
H342 mainly targets nuclear processes, in particular, transcription
regulation (30%). Thus, it is likely that downregulation of the
genes of transcription regulation is the H342-specific gene
expression signature.
Identification of signal transduction pathways consisting
of these gene signatures
H258-upregulated and H342-downregulated genes that involve
transcription regulation are the signatures of differential global
gene expression profiles induced by H342 and H258. Comparing
these two sets of genes shows a statistically significant overlap of
only 7 genes, the majority of which is regulated in the same
direction (Figure 8). To further find the enriched pathways of the
two gene sets related to H342- and H258-induced transcription
regulation, we performed an overrepresentation pathway analysis
on Genomatix. Under the threshold of a P value of ,0.05, there
are 35 enriched pathways for 26 H258-upregulated genes and 10
enriched pathways for 148 H342-downregulated genes. Of the 10
enriched pathways for H342-downregulated genes (Table 2), 9,
except for the vitamin D receptor, overlap with the pathways for
H258-upregulated genes. Of the 7 shared genes, 5 genes (e.g.
Cited2, DDIT3, Isl1, id1 and MSC) involve 8 H342-enriched
pathways. These data further prove both Hoechst dyes may share
the same primary targets.
Discussion
Hoechst 33342 (H342) is a novel apoptotic inducer in different
types of cancer cell lines [17] and species [28]. Conventionally,
Figure 4. Antagonistic effect of H258 on H342-induced cell
death in H2373 cells. A, Cell viability was determined by MTT assay
after H2373 cells were treated by H342 or H258 alone, H258
pretreatment for 1 h followed by H342 treatment, or combination of
H342 + H258 for different times. B, Antagonistic effect between H342
and H258 was analyzed by Calcusyn software to generate a dose
response curve. Fa represents the fraction of cells that is growth
inhibited in response to H342 and/or H258. This is calculated as 1 2
fraction of surviving cells. Fa values for each treatment were used to
conduct synergy analysis by CalcuSyn software as described in Materials
and Methods.
doi:10.1371/journal.pone.0025822.g004
Table 1. Combination indices for H342 and H258 treatment
for 24 h, as computed by CalcuSyn for H2373 cells.
H342 (mM) Fa H258 (mM) Fa
H342+H258
(Fa) CI
4.5 0.0133 18 0.0054 0.0329 1.186
9 0.3218 36 0.0231 0.1735 1.416
13.5 0.8759 72 0.0391 0.2392 1.918
18 0.9342 108 0.1133 0.3050 2.356
Note: CI (combination indices).1 indicates antagoniusm; Fa, fraction affected.
doi:10.1371/journal.pone.0025822.t001
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mediated by mitochondria, resulting in the activation of caspase 9,
or the extrinsic pathway mediated by the activation of death
receptors (Fas and TNFR), involving the activation of caspase 8
[17], [37]. Cytochrome c release is a crucial step in the
mitochondrial or intrinsic pathway due to its ability to activate
caspase 3. Since both the extrinsic and intrinsic pathways converge
at caspase 3, cytochrome c release can be used to determine the
pathway involved. Capase 3, together with other effector caspases
(such as caspase 7 and 6), orchestrates the dismantling of diverse
cell structures through cleavage of specific substrates [38].
Caspases, including caspase 3, exist as inactive proenzymes that
undergo proteolytic processing at conserved aspartic residues to
produce a cleaved active enzyme that is detected by immunoblot.
A classical substrate for caspase 3 is poly ADP ribose polymerase
(PARP). Our results show that degradation of PARP, inhibition of
apoptosis protein 1 (c-IAP1), c-IAP2, and survivin are associated
with a decrease in pro-caspase 3 levels and an increase in caspase 3
activity that are related to cytochrome c translocation from the
mitochondria to the cytosol. Degradation of PARP impairs the
DNA repair process, whereas c-IAP1, c-IAP2 and survivin
downregulation disarms their antiapoptotic capacity [39], thus
enhancing the apoptosis process. However, it is important to note
that in this study, the signal of cleaved caspase 3 is undetected by
immunoblotting. This raises the question of whether the synthetic
peptide corresponding to residues that have been used for
antibody generation is not included in the activated caspase 3
when H342-induced cleavage occurs, indicating the possibility of
other cleavage sites for caspase 3 activation. Overall, H342-
induced apoptosis is an intrinsic pathway-dependent apoptosis that
is characterized by not only a morphological hallmark, but also the
key biochemical features of apoptosis, including mitochondrial
membrane potential [33], externalization of membrane phophoa-
tidylserine [40], DNA fragmentation [40], [41], activation of
caspase 3 associated with cytochrome c release (Figure 1C) [42],
and cleaved caspase 3 substrates (Figure 1D). Moreover, H342-
induced apoptosis is also associated with dysfunctions of Lactate
oxidation [32] and fatty acid anabolism [43]. Thus, H342-induced
apoptosis is complicated and still remains unclear.
Malignant pleural mesothelioma (MPM) is a deadly and
asbestos-associated disease with patient survival from presentation
of ,12 months [44]. Unfortunately, no single therapy has proven
effective in curing MPM, presumably because of the multiplicity of
survival and chemoresistance pathways in these tumors [45].
Substantial improvements in survival will require the development
of novel and more effective pharmacological interventions. In
addition, nearly all MPM patients progress during or after first-line
treatment, and second-line chemotherapy is being increasingly
used in clinical practice. Therefore, second-line therapy of MPM
remains an ideal field in which to test new chemotherapy agents as
Figure 5. Differential gene expression profiles induced by H258 and H342. Venn diagram (left) illustrating overlap between changes
identified with H342- and H258-induced differential gene expression profiles. Hierarchical cluster (middle) indicating differential gene expression
induced by H258 and H342: red (up-regulated) and green (down-regulated). Gene ontology analysis (right) (P-values represent a Bonferroni-corrected
EASE score). These genome-wide gene expression profiles were normalized by untreated H2373 cell gene expression profile.
doi:10.1371/journal.pone.0025822.g005
Molecular Mechanisms of DNA Minor Groove Binders
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25822well as new therapeutic strategies, including anti-angiogenic
compounds, small molecules or monoclonal antibodies that target
different molecular pathways [46]. In the present study, H342 acts
as a potent apoptotic inducer in mesothelioma cell lines, which
indicates that MBs may hold promise as a novel therapeutic
approach for MPM treatment.
Hoechst dyes are utilized for staining DNA to evaluate the cell
cycle and apoptosis, and quantify viable cells in molecular biology
[17]. H342 efflux technique has been widely used for identifying
side population cells from a variety of tissues and species, including
cancer cell lines and tissues. The efflux ability of the cells has been
attributed to the high expression of the ATP binding cassette
(ABC) transporter G2 and multidrug resistance protein 1 [47].
However, the mechanism by which a cell readily takes up Hoechst
dyes remains unclear. The present results show that pretreatment
of H258 for one hour fails to protect H2373 cells from H342-
induced apoptosis, and H342 approaches its maximum peak
emission spectra for the formation of H342-DNA complexes in
spermatozoa after a 30 minute incubation period [48], thus
indicating the antagonistic effect of H258 on H342-induced
apoptosis is not associated with pre-occupied AT-rich DNA
sequences by H258 (Figure 3A). However, since H342-induced
apoptosis is partially blocked by H258, this implies that Hoechst
dyes at least partially share the same transport system. Previous
literature has suggested that H342 enters the cell by an
unmediated diffusion transport mechanism through the cell
membrane prior to DNA binding [48], [49]. In addition, our
initial data shows that the components of the cell culture media
affect the potency of H342-induced apoptosis [41]. Antagonism
between Hoechst dyes and among Hoechst dyes and other
components of the media may imply that there is existence of a
mediated transport mechanism involving Hoechst uptake. There-
fore, further experiments are required to determine whether or not
Hoechst dyes pass through the cell membrane by not only simple
diffusion, but also by mediated transport mechanisms. Our present
result suggests that the pharmacokinetic reason for the two
Hoechst dyes’ diverse biological effects on the cell is due to
differences in cell membrane transport of the two dyes into the
cell.
In the present study, our gene expression profiles in response to
the treatment of the two Hoechst dyes show differential global
gene expression profiles with unique gene expression signatures.
It is likely that upregulation of the transcription regulation genes
and downregulation of the nuclear structure and cell cycle genes
Figure 6. Real-time RT-PCR for microarray data validation. A, Four gene products of the real-time RT-PCR were visualized after separation on
an agarose gel. B, Comparing differences of PCR cycles of four genes.
doi:10.1371/journal.pone.0025822.g006
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This signature discloses the molecular mechanisms behind
previous findings: inhibition of constitutive heterochromatin
condensation [50], prolongation of the G2 cycle [51], and
enhancement of transgene overexpression [25]. In contrast to the
H258 signature, it is likely downregulation of the genes involved
in transcription regulation is the H342-specific gene expression
signature. Consistent with H342-response gene expression
signature, H342-induced apoptosis is not related to de novo
synthesis of RNA and proteins [32], which is associated with
rapid degradation of multiple critical proteins such as replication
protein A [12], TATA box binding protein [10], fatty acid
synthase [43]. There are approximately 2600 proteins in the
human genome that contain DNA-binding domains, and most of
these are presumed to function as transcription factors [52].
Thus, only a paucity of transcription regulation genes (less than
7% of the total transcription regulation genes) are affected by
Hoechst dyes, indicating that Hoechst dyes are highly specific
DNA binders. Of the 10 enriched pathways for 148 H342-
downregulated genes of transcription regulation, 9 (except for the
vitamin D receptor) overlap with the pathways for H258-
upregulated genes of transcription regulation in enriched
pathway analysis of the signatures of these two dyes, demon-
strating their sharing similar primary targets. Since H342-
downregulated genes of transcription regulation involve some
critical pathways for cell survival and development such as Notch
and TGF-b, etc (Tables 2) H342 like other DNA minor groove
binders may be unnecessarily over-targeting many vital genes in
the cells, which results in extreme intolerance [14]. Therefore,
choosing some pathways targeted by H342 for pathway-targeted
cancer therapy may be a way to minimize cytotoxicity and
maximize therapeutic effectiveness of DNA minor groove
binders. It is worth mentioning that several expected targets,
such as helicase and topoisomerase I and II, are not detected by
microarray analysis, suggesting that helicase and topoisomerases
may not be the initial targets of Hoechst dyes. The gene
expression profile induced by camptothecin, a typical inhibitor of
topoisomerase I, is characterized by downregulated genes
involved in DNA metabolism and mitosis, and upregulated genes
related to DNA damage stimulus and cell cycle arrest [53]. These
differential gene expression profiles induced by camptothecin and
the two Hoechst dyes demonstrate that drug-induced gene
signatures may provide valuable information for drug reclassifi-
cation, efficacy prediction, and toxicity evaluation.
Materials and Methods
MPM cell lines and Reagents
Seven cell lines (H2373, H2452, H2596, H2461, H2591, H-
meso, and H2714) derived from patients with malignant plural
mesothelioma were cultured in RPMI 1640 (HyClone) supple-
mented with 100 units/ml of penicillin, 100 mg/ml streptomycin,
and 10% fetal calf serum (HyClone) [54], [55], [56]. Anti-PARP
antibody was purchased from Biomed. Anti-caspase-3 antibody
was purchased from Cell Signaling Technology and anti-actin
antibody was from Sigma. Antibodies against survivin, c-IAP1,
and c-IAP2 were from Santa Cruz Biotechnology, Inc. Anti-
cytochome c antibody was from BD Bioscience. Fluorogenic
caspase-3 specific substrate Ac-Asp-Glu-Val-Asp-AMC was from
EMD Chemicals.
Figure 7. H342 downregulates SNIP1-stimulated gene expression of c-Myc target genes that are associated with mitochondrial
function in H2373 MPM cells. A, Four gene products of the real-time RT-PCR were visualized after separation on an agarose gel. B, Comparing
differences of PCR cycles of four genes. C, Schematic diagram of H342-induced mitochondria dysfunction through SNIP1 and COX19. In untreated
H2373 MPM cells, C-terminus of nuclear protein SNIP1 interacts with the N-terminal c-Myc, resulting in enhanced transcriptional activation of c-Myc-
dependent genes [30]. In addition, COX19 participates in the biogenesis mitochondrial respiratory chain complexes [35]. H342 rapidly attenuates
gene expression of SNIP1 and consequently causes downregulation of c-Myc target genes such as TFAM, resulting in downregulation of gene
expression of mitochondria such as COX1 [34]. COX19 downregulation fail to organize cytochrome c oxidase. Overall, these alterations of gene
expression induced by H342 may lead to mitochondrial dysfunction, for good reason-H342-induced apoptosis is a mitochondria-mediated apoptosis.
doi:10.1371/journal.pone.0025822.g007
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Determination of cell viability was studied using the MTT
assay. Cells were seeded in a 96-well culture plate and
subsequently treated with indicated agents for different times.
After treatment, the cells were incubated with 0.5 mg/ml MTT
reagent (Sigma) at 37uC for 3 h and then MTT medium was
removed and 100 mL of DMSO added, followed by colorimetric
analysis using a Victor3 Multilabel Plate Reader at 570 nm
(Perkin Elmer). Results were plotted as the mean from triplicate
experiments.
Figure 8. Comparison of gene expression signatures induced by H258 and H342. Heat map showing kinetics of changes in expression of
transcription regulation genes identified in H342- and H258-induced global gene expression profiles based on DAVID Bioinformatics Database gene
descriptions.148 H342-downregulated transcription regulation genes (left). Venn diagram (middle) illustrating 7 overlapped genes between H342-
downregulated and H258-upregulated genes of transcription regulation. 26 H258-upregulated transcription regulation genes (right).
doi:10.1371/journal.pone.0025822.g008
Table 2. Pathways in which 148 H342-downregulated genes of transcription regulation involved.
Pathways P-value # Genes (obsreved) # Genes (total)
NOTCH 7.72E-07 20 580
TGF BETA 6.34E-06 31 1408
RETINOBLASTOMA 1 1.98E-05 12 277
MOTHERS AGAINST DPP HOMOLOG 1.49E-04 19 758
WINGLESS TYPE 2.62E-03 19 954
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2.73E-03 10 350
HISTONE DEACETYLASE 3.49E-03 8 247
TUMOR PROTEIN P53 3.95E-03 19 989
ARYL HYDROCARBON RECEPTOR 7.14E-03 6 168
VITAMIN D (1,25 DIHYDROXYVITAMIN D3) RECEPTOR 8.21E-03 5 123
doi:10.1371/journal.pone.0025822.t002
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Combination index (CI) method adapted for in vitro drug testing
was used to determine the nature of interaction between the two
agents as described previously [57]. CI was generated from MTT
data by CalcuSyn software (Biosoft). Based on CI values, the
extent of synergism/antagonism may be determined. In general,
CI,1 suggests synergy, whereas CI .1 indicates antagonism
between the drugs.
Morphology Studies and Hoechst 33342 Staining
The treated and untreated H2373 cells were washed twice in
PBS and fixed in PBS containing 1% paraformaldehyde. The
morphology of the cells was then studied and photographed with a
microscope.
Hoechst 33342 staining was used to observe the nuclear
morphology of the cells through fluorescence microscope using a
320 to 350 nm filter. Untreated and treated cells were rinsed with
PBS buffer and stained with Hoechst 33342 (final concentration,
18 mM) for 10 minutes. After staining with Hoechst 33342, the
morphological aspects of cell nuclei were observed with a
fluorescence microscope.
Caspase-3 activity assay
Intracellular caspase-3 activities in cell extracts were determined
by measuring the release of the AMC groups from a caspase-3
specific substrate Ac-Asp-Glu-Val-Asp-AMC. The treated and
untreated cells were harvested. Cell extracts were prepared using
RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1.0% IGEPAL
CA-630, 0.5% sodium deoxycholate, 0.1% SDS) with protease
inhibitor cocktail (Sigma). The cell extract (30 mg) was then
incubated in 100 ml of the reaction buffer (50 mM Tris–HCl,
pH 7.5) along with 40 mM of caspase-3 substrate in a 96-well
plate. The reaction mixture was incubated at room temperature
for 10 min and the hydrolyzed fluorescent AMC groups were
measured using a Victor 3 Multilabel Counter with an excitation
filter of 380 nm and an emission filter of 460 nm (Perkin Elmer).
Mitochondria isolation and cytochrome c release assays
Isolation of mitochondria and cytochrome c release assays were
performed by differential centrifugation as described previously
[58]. In brief, untreated and treated cells were homogenized in
HM buffer (10 mM HEPES, pH 7.4, 250 mM mannitol, 10 mM
KCl, 5 mM MgCl2, 1 mM EGTA) containing 1 mM phenyl-
methylsulfonyl fluoride and protease inhibitor cocktail (Sigma).
The homogenate was centrifuged twice at 1000 6g for 5 min to
remove nuclei and debris, and the resulting supernatant was
centrifuged at 10,0006g for 10 min to sediment the low speed
fraction containing mitochondria. The mitochondria were washed
twice with the HM buffer and resuspended in RIPA buffer with
protease inhibitor cocktial (Sigma). The purity of cytosolic and
mitochondrial fractions is determined by flow cytometry when the
two fractions are stained by JC1, a specific mitochondrial indicator
(Figure S1) [33]. For detection of cytochrome c release,
cytochrome c concentrations in the cytosol and the mitochondria
were determined by immunoblotting with anti-cytochrome c
antibody (BD Pharmingen) as described below.
Measurement of apoptosis-associated proteins by
Immunoblotting
Proteins (30 mg) from either total cell lysates or cytosolic and
mitochondrial fractions of untreated and H342-treated H2373
cells were separated by 12% SDS-PAGE and then transferred
onto PVDF membranes. The membrane was incubated with
antibodies against the following proteins: PARP, c-IAP1, c-IAP2,
survivin, caspase 3, cytochrome c and b-actin. Secondary
antibodies conjugated with horseradish peroxidase were visualized
with enhanced-chemiluminescence substrates (Pierce).
RNA extraction
Total RNA from the untreated and treated H2373 mesotheli-
oma cells was extracted using RiboPure
TM Kit (Ambion),
according to the manufacturer’s instruction manual.
Microarray Expression Profiling
Microarray expression profiling was performed by the Applied
Genomics Technology Center (Wayne State University). The
RNA was amplified into cRNA and biotinylated by in vitro
transcription using the IlluminaH TotalPrep RNA Amplification
Kit (Ambion) according to the manufacturer’s protocol. Biotiny-
lated cRNAs were purified, fragmented, and subsequently
hybridized to an Illumina Human-12 v4 Expression BeadChip
(Illumina). Microarray data have been submitted to the Gene
Expression Omnibus (GEO) database (accession no.GSE28616).
All data is MIAME compliant.
Global gene expression analysis and signal pathway
analysis
Functional interpretation of differentially expressed genes was
analyzed in the context of gene ontology using the DAVID
Bioinformatics Resources 6.7 (http://david.abcc.ncifcrf.gov/).
The differentially expressed genes induced by two Hoechst dyes
were categorized, compared to genetic categories in the David
database, and ranked according to p-values [36]. Hierarchical
clusters of global gene expression profiles were analyzed by the
Mev version 4.5.1software and enriched pathways of gene
expression signatures were analyzed by Genomatix software.
Real-time RT-PCR for microarray data validation
To validate microarray data, 50 ng of total RNA was reverse
transcribed using MMLV reverse transcriptase enzyme (Promega)
in the presence of the RNase inhibitor RNAsin (2 units/ml)
(Promega). Real-time PCR amplification was performed with the
ABsolute QPCR SYBR Green Mix (Thermo Scientific) on a MJ
Research DNA Engine Opticon (MJ Research). The initial
denaturation step was at 95uC for 5 min, followed by 40 cycles
of amplification at 95uC for 30s, 60uC for 30s and 72uC for 30s.
PCR products were separated on a 2% agarose gel and stained
with ethidium bromide. The primers used in the real-time PCRs
are shown in additional file1: Table S1.
Statistical analysis
Statistical differences between treatment groups were measured
using a Student’s t-test. P-values ,0.05 were considered significant.
Supporting Information
Figure S1 Determination of the amounts of the mitochondria in
different fractions after fractionating the mitochondria from
cultured H2373 MPM cells. The mitochondria of H2373 cells
were extracted using the centrifuge-based method [58]. A,
Mitochondrial fraction without JC-1 staining (0.2% mitochondria
or UL+UR areas); B, Supernatant after first centrifuge (55.29%);
C, Cytosolic fraction (15%) after second centrifuge; D, Mitochon-
drial fraction (99.11%) after second centrifuge. Since protein
abundance is higher in the cytosolic fraction than that in the
mitochondrial fraction, the ratio of mitochondrial amounts
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protein amount that you load for the SDS-PAGE gel.
(TIF)
Table S1 Primer sequences used for real-time RT-PCR in
microarray validation analysis.
(DOC)
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